Literature DB >> 17579582

Activation of CFTR-specific T Cells in cystic fibrosis mice following gene transfer.

Maria P Limberis1, Joanita Figueredo, Roberto Calcedo, James M Wilson.   

Abstract

Gene therapy for cystic fibrosis (CF) airway disease has emerged as a potentially successful therapy, because expression of the CF gene would be expected to restore the electrophysiological function of the airway epithelium to normalcy. Although, cellular and humoral immune responses to viral gene transfer vectors have been studied extensively, there has been no evaluation of T cell-mediated responses to the therapeutic human CF gene product. Using an adenovirus vector we demonstrated that T cells against human CF gene protein are elicited in CF gene knockout (KO), heterozygote (Het), and wild-type (wt) mice. A dominant CD8 T cell epitope found in CF gene KO, Het, and wt mice was mapped to NTYLRYITV. In CF gene KO mice we also identified (to a conserved region of the CF gene CSQFSWIMPGTIKEN), a minor T cell epitope that did not show any activity in the Het or wt mice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17579582     DOI: 10.1038/sj.mt.6300210

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  13 in total

1.  TLR9 signaling mediates adaptive immunity following systemic AAV gene therapy.

Authors:  Scott N Ashley; Suryanarayan Somanathan; April R Giles; James M Wilson
Journal:  Cell Immunol       Date:  2019-10-26       Impact factor: 4.868

2.  Alternative Start Sites Downstream of Non-Sense Mutations Drive Antigen Presentation and Tolerance Induction to C-Terminal Epitopes.

Authors:  Scott N Ashley; Suryanarayan Somanathan; Christian Hinderer; Maxwell Arias; Deirdre McMenamin; Christine Draper; James M Wilson
Journal:  J Immunol       Date:  2017-05-12       Impact factor: 5.422

Review 3.  Advances in cell and gene-based therapies for cystic fibrosis lung disease.

Authors:  Mayumi Oakland; Patrick L Sinn; Paul B McCray
Journal:  Mol Ther       Date:  2012-02-28       Impact factor: 11.454

4.  Inflammation promotes the loss of adeno-associated virus-mediated transgene expression in mouse liver.

Authors:  Ekaterina Breous; Suryanarayan Somanathan; Peter Bell; James M Wilson
Journal:  Gastroenterology       Date:  2011-04-12       Impact factor: 22.682

Review 5.  Ferret and pig models of cystic fibrosis: prospects and promise for gene therapy.

Authors:  Ziying Yan; Zoe A Stewart; Patrick L Sinn; John C Olsen; Jim Hu; Paul B McCray; John F Engelhardt
Journal:  Hum Gene Ther Clin Dev       Date:  2015-02-12       Impact factor: 5.032

6.  Hepatic regulatory T cells and Kupffer cells are crucial mediators of systemic T cell tolerance to antigens targeting murine liver.

Authors:  Ekaterina Breous; Suryanarayan Somanathan; Luk H Vandenberghe; James M Wilson
Journal:  Hepatology       Date:  2009-08       Impact factor: 17.425

7.  BALB/c mice show impaired hepatic tolerogenic response following AAV gene transfer to the liver.

Authors:  Ekaterina Breous; Suryanarayan Somanathan; James M Wilson
Journal:  Mol Ther       Date:  2010-01-12       Impact factor: 11.454

8.  Self-reactive CFTR T cells in humans: implications for gene therapy.

Authors:  Roberto Calcedo; Uta Griesenbach; Daniel J Dorgan; Samia Soussi; A Christopher Boyd; Jane C Davies; Tracy E Higgins; Stephen C Hyde; Deborah R Gill; J Alastair Innes; David J Porteous; Eric W Alton; James M Wilson; Maria P Limberis
Journal:  Hum Gene Ther Clin Dev       Date:  2013-07-19       Impact factor: 5.032

Review 9.  On the Corner of Models and Cure: Gene Editing in Cystic Fibrosis.

Authors:  Marjolein Ensinck; Angélique Mottais; Claire Detry; Teresinha Leal; Marianne S Carlon
Journal:  Front Pharmacol       Date:  2021-04-27       Impact factor: 5.810

10.  Activation of transgene-specific T cells following lentivirus-mediated gene delivery to mouse lung.

Authors:  Maria P Limberis; Christie L Bell; Jack Heath; James M Wilson
Journal:  Mol Ther       Date:  2009-09-01       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.